Welcome to Jacksonville Center for Clinical Research


Clinical trials move medicine forward. Sponsors, such as pharmaceutical companies, governments and foundations fund medical research. Patients who participate in clinical research receive many advantages including treatment at no cost, access to expertise and resources such as expensive tests. Research volunteers shape the future and can have fun while helping others and themselves.

 

As a premier clinical research organization, we have conducted more than 2,500 clinical trials over 20 years and have worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you.


Shape the Future

Clinical research is a process that gives back. Volunteers generate information that improves future health care outcomes for everyone.

Find relief with new treatments

Volunteers join research to seek relief from affliction and to better understand their conditions with support from our caring team.

Programs Offer Resources or Pay

Study participants receive medical tests, services, counseling and treatment at no charge. These measures may be unavailable to the general public!


We do research in many areas


Lupus

Lupus
 

Health insurance is not required to participate in our research studies.
Ask your doctor or contact our clinic for more information
(904) 730-0166

Low Testosterone

Low Testosterone


Health insurance is not required to participate in our research studies.
Ask your doctor or contact our clinic for more information
(904) 730-0166





View all active studies

Our Volunteers Love Us


Watch what they have to say about their research experience!



Postpartum Depression Research Testimonial
Phase 1 Research Joe's Experience
Phase I Research Terry's Experience

Sign Up


I'm interested in... (Scroll to select multiple)































Our Staff

View All

Amber Devries

Amber has been at Jacksonville Center for Clinical Research since 2007 and along the way she has acquired many hats. She is the assistant site manager, a clinical research coordinator, the office party planner, and a birthday card making committee of one.

Amber graduated with a degree in biology from Jacksonville University. While there, she played on the women's soccer team, and between games she met her husband Kyle, who pitched for the JU baseball team. She still gets such a kick out of soccer that she is currently coaching a team of 5 year olds.

If you think Amber isn’t occupied enough at work and play, she also stays busy with two active sons and a toddler girl!

Amanda Elwood

At ENCORE Research Group we have many employees who work behind the scenes and never get to meet patients. Amanda Elwood is a prime example, as she is a Regulatory Specialist at our Jacksonville office handling regulatory compliance and lots of the paperwork it takes to get new studies started. She has been with us since 2014.

To say Amanda loves animals is an understatement, since she has three dogs and four cats. We have to agree with her when she says “It’s a lot of work, but the snuggling makes it worth it!”

Amanda was born in Puerto Rico and she loves Hispanic foods! Some of her favorites are tostones, empanadillas and picadillo.

She is obsessed with The Walking Dead and Game of Thrones. She also collects postcards from all of the places she visits. She spent a summer studying abroad and collected postcards from Switzerland, Amsterdam, France, and Italy.

Joyce Williams

If you have ever stepped foot into the Jacksonville Center for Clinical Research building on University Blvd. then you have probably met Joyce M. Williams. Joyce has been the Director of First Impressions here since March 2, 1998, and she became the first African American shareholder at JCCR in 2003.

Joyce is an ordained minister! She attended Jacksonville Theological Seminary and graduated in May 2007 with an Associates Degree in Religious Arts of Biblical Studies. She is very involved in her church; she is the Lead Vocalist, #1 Choir Director, Church Secretary, President of the Missionary Board, and Deaconess.

If all of this doesn't keep Joyce busy enough, she also collects thimbles - she has over one hundred! She also loves to color large coloring pads and books. Some of Joyce's favorite foods are spaghetti, fried chicken and seafood. If you have met Joyce, you can agree that she has a great love for her job and all the people that she meets. 

Lastest Blog Post:


"Pneumonia" the old man's friend

"Pneumonia" the old man's friend. The most frequent "sendoff" in the pre antibiotic era. In the US infectious disease remains a leading cause of death primarily due to pneumonia. Each year the bacteria Streptococcus pneumonia (pneumococcal) disease kills thousands of adults. It is spread from person to person through, coughing, sneezing and close contact. People can carry the bacteria in their throat, nose and sinuses and show no symptoms of infection and still spread the bacteria to people who do become ill. Illness can range from upper respiratory tract infections; sinus, ears and throat to much more severe disease (invasive pneumococcal disease, IPD) defined as pneumonia, blood stream infection and meningitis. There are dozens of different types of pneumococcus that vary by polysaccharides in the capsule that surrounds them. 
 
Vaccination against pneumococcal disease started in the pediatric age group and was quickly shown to be highly effective and then introduced to the adult population with similar results. It has been proven that vaccines against pneumococcus are safe and effective and DON'T CAUSE autism. Current recommendations are that adults 65 years old should receive 2 vaccines separated by at least one year. Re-vaccination with the same vaccine is generally not recommended.  PCV13 followed by PPSV23 after 1 year. The number on the vaccine tells you how many different types of pneumococcus are covered. Long term studies have shown a 75% reduction in IPD in adults after one dose of PCV13 or PPSV23 for the covered types and an overall 45% reduction against pneumococcal infections in general. Estimates for the U.S. project a vaccine related reduction of 3,000 deaths and 30,000 cases of IPD over the next 3 years.
 
Monitoring pneumococcal sub-types in the community allows us to produce more effective vaccines based on the sub-types identified. ENCORE Research Group is excited to participate in new pneumonia vaccine research! If you or someone you know may be interested in participating in our research, call our office to find out more! 

Pneumonia vaccine research is currently enrolling at:
Jacksonville Center for Clinical Research
Nature Coast Clinical Research – Crystal River
 
Written By:
Mitchell Rothstein, MD

View the full blog